NDAQ vs CME
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
NDAQ
CME
Investment Advisor Scores
CME
Oct 23, 2026AI Analyst Insights
Detailed Metrics Comparison
| Metric | NDAQ | CME | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.6407 | 21.9298 | CME |
| PEG Ratio | 1.7643 | 4.7092 | NDAQ |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 14.9% | 0.8% | NDAQ |
| Earnings Growth | 14.1% | 2.5% | NDAQ |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 40.9/100 | 32.8/100 | NDAQ |
| Profit Margin | 35.0% | 63.4% | CME |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
| Implied Volatility | N/A | N/A | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NDAQ
NeutralMixed signals - no dominant trend phase, RSI 72
CME
MarkupPrice above SMA50, rising 50-day trend (3.2% over 20 days), RSI 78
Fundamentals Snapshot
| Metric | NDAQ | CME |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 21.9 | 23.2 |
| Trailing P/E | 28.0 | 24.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.5% | 0.7% |
| EPS | 3.69 | 12.62 |
| Dividend Yield | 0.00% | 0.00% |